세계 헬스어용 확장현실(XR) 시장은 예측 기간(2024-2031년) 동안 연평균 16.2%의 성장률을 나타낼 것으로 예상됩니다. 특히, 최근 세계 보건 위기로 인해 원격 진료에 대한 수요가 증가하고, 고급 교육 방법의 필요성, 의료 기관에서 익스트림 프로그래밍(XP) 기술에 대한 투자 확대 등이 시장 성장의 주요 요인으로 작용할 것으로 보입니다. 또한, 원격 의료 기술의 발전은 헬스케어 분야의 증강현실 분야에 긍정적인 영향을 미치고 있습니다. 그러나 높은 기기 가격과 의료 환경에서의 사용에 대한 표준화된 규정의 부재로 인해 시장도 문제에 직면하고 있습니다.
기술 중에서도 AR 하위 부문은 의료용 XR 시장에서 상당한 점유율을 차지할 것으로 예상되며, 수술이나 진단과 같이 실시간 데이터 오버레이가 필요한 시술에서 AR이 점점 더 중요해지고 있습니다. 의료 서비스 제공업체의 인지적 부담을 줄이는 등의 이점을 제공합니다. 헤드 마운트 디스플레이 및 스마트 안경과 같은 웨어러블 기술은 작업자가 활동을 완료할 때 데이터와 가상 지침을 제공하여 핸즈프리 접근 방식을 제공하며, AR 기반 이미지 시각화는 외과의사를 지원하고 복잡한 수술 중 정확성과 정밀도를 향상시키기 위해, AR 기술을 사용하여 의료 프로세스의 효율성을 높일 수 있습니다. 예를 들어, 2023년 12월 Augmedics는 xvision Spine System으로 5,000명의 환자가 치료를 받았다고 발표했습니다. 두 시스템 모두 FDA의 수술 승인을 받은 최초의 AR 내비게이션 시스템이며, 미국에서 처음으로 수술에 사용되었습니다.
세계 의료용 증강현실 시장은 북미(미국, 캐나다), 유럽(영국, 이탈리아, 스페인, 독일, 프랑스, 기타 유럽), 아시아태평양(인도, 중국, 일본, 한국, 기타 아시아 지역), 기타 지역(중동 및 아프리카, 라틴아메리카) 등 지역별로 세분화되어 있습니다. 세분화되어 있습니다. 그 중에서도 아시아태평양은 의료 인프라의 개선으로 인해 세계 시장에서 두드러진 점유율을 차지할 것으로 예상됩니다. 중국, 인도, 일본과 같은 신흥 경제 국가들은 헬스케어 산업에서 AR 및 VR 기술 개발 및 유통과 관련된 아웃소싱 서비스에 매력적인 선택지를 제시하고 있습니다.
전 세계 지역 중 북미는 탄탄한 의료 인프라, R&D 활동에 대한 투자, 유리한 정부 이니셔티브, 기술에 대한 막대한 투자로 인해 예측 기간 동안 상당한 CAGR로 성장할 것으로 예상됩니다. 또한, 이 지역에는 증강현실 및 헬스케어 기술 분야의 선도적인 기업들이 존재하여 시장 성장을 가속하고 있습니다. 신경외과 및 흉부외과를 위한 첨단 VR 도구는 외과의사가 수술 전에 환자의 뇌와 신체를 가상으로 탐색할 수 있게 해줍니다. 이를 통해 외과의사는 수술 전에 환자의 해부학적 구조를 가상으로 탐색할 수 있습니다. 또한, VR은 최근 소아과에서 바늘을 이용한 정맥주사 시술을 받는 어린이들의 통증과 공포를 줄이기 위해 소아과 현장에서 사용될 수 있습니다. 예를 들어, 2023년 3월, 캐나다 어린이 병원(Shriners Hospitals for Children Canada)은 4년간의 연구 끝에 VR을 진료 과정에 통합했습니다. 이 인터랙티브 기술을 통해 어린이들은 의료 절차를 받는 동안 VR을 사용할 수 있어 불안과 통증을 줄일 수 있습니다. 지속적인 노력을 통해 병원은 2024년에 약 3,500명, 향후 5년간 최대 17,500명의 환자에게 VR을 제공할 수 있습니다.
Global Healthcare Extended Reality Market Size, Share & Trends Analysis Report by Component (Software & Services and Hardware), by Technology (Augmented Reality (AR), Virtual Reality (VR), and Mixed Reality (MR)), and by Application (Medical Training and Education, Surgical Planning, Rehabilitation & Therapy, and Patient Care & Monitoring), and by End-User (Hospitals, Clinics & Surgical Centers, Pharmaceutical & Biotechnology Companies, Research Organization & Diagnostics Laboratories, and Government & Defense Institutions) Forecast Period (2024-2031)
The global healthcare extended reality market is anticipated to grow at a CAGR of 16.2% during the forecast period (2024-2031). The rising need for remote medical consultations is especially accentuated by recent global health crises, the need for advanced training methods, and the growing investments in Extreme Programming (XP) technology by healthcare organizations are some of the major factors contributing to the market growth. Additionally, advances in telemedicine technologies are positively affecting the extended reality sector within healthcare. However, the market also faces challenges due to the high cost of devices and the lack of standardized regulations for their use in healthcare settings.
The global healthcare extended reality market is segmented by component, technology, application, and end-user. Based on the component, the market is sub-segmented into software & services, and hardware. Based on the technology, the market is sub-segmented into AR, VR, and MR. Based on the applications, the market is sub-segmented into medical training and education, surgical planning, rehabilitation and therapy, and patient care & monitoring. Further, based on the end-users, the market is sub-segmented into hospitals, clinics & surgical centers, pharmaceutical & biotechnology companies, research organizations and diagnostics laboratories, and government & defense institutions. Among the end-users, the hospitals, clinics, and surgical centers sub-segment is anticipated to hold a considerable share of the market. Extended reality technologies provide significant benefits considering the scope and diversity of medical processes and patient interactions. This increases surgical accuracy, expedites diagnostic processes, and improves patient engagement. Investments in extended reality technologies by healthcare organizations are set to grow in the coming years, further solidifying their role as the primary end-users.
Among the technology, the AR sub-segment is expected to hold a considerable share of the healthcare extended reality market. AR is becoming increasingly crucial for procedures that require real-time overlays of data, such as surgeries and diagnostics. It offers benefits such as reduced risk and less cognitive load for healthcare providers. Wearable technology, such as head-mounted displays and smart glasses, provide a hands-free approach to perform work by providing data and virtual instructions to workers as they complete activities. The efficiency of healthcare processes can be enhanced by using AR technologies as AR-based image visualization assists surgeons and enhances their accuracy and precision during complex surgeries. For instance, in December 2023, Augmedics announced 5,000 patients treated with its xvision Spine System. Both were the first AR navigation systems to gain FDA approval for surgery and the first to be used in surgery in the US.
The global healthcare extended reality market is further segmented based on geography including North America (the US, and Canada), Europe (UK, Italy, Spain, Germany, France, and the Rest of Europe), Asia-Pacific (India, China, Japan, South Korea, and Rest of Asia), and the Rest of the World (the Middle East & Africa, and Latin America). Among these, Asia-Pacific is anticipated to hold a prominent share of the market across the globe, owing to the improving healthcare infrastructure. Emerging economies such as China, India and Japan present attractive options for outsourcing services associated with the development and distribution of AR and VR technology in the healthcare industry.
Among all regions, the North American region is anticipated to grow at a considerable CAGR over the forecast period due to its robust healthcare infrastructure, investment in R&D activities, favorable government initiatives, and significant investments in technology. Additionally, the presence of leading extended reality and healthcare technology companies in the region boosting the market growth. Advanced VR tool for neurosurgery and thoracic surgery, enables surgeons to virtually explore a patient's brain and body before performing a procedure. It enables surgeons to virtually explore a patient's anatomy prior to performing a procedure. Furthermore, VR is a more recent form of distraction that may have been used in the pediatric setting for reducing pain and fear in children undergoing needle-based intravenous procedures. For instance, in March 2023, Shriners Hospitals for Children Canada integrated VR into its care processes after four years of research. The use of this interactive technology allows children to use VR, while undergoing medical procedures reducing anxiety or pain they may experience. With sustained efforts, the hospitals could offer VR to approximately 3,500 patients in 2024 and up to 17,500 patients over the next 5 years.
The major companies serving the global healthcare extended reality market include Sony Corporation, Magic Leap, Medtronic, Surgical Theater, Inc., Osso VR, AppliedVR, BioflightVR, Fundamental Surgery, Fusion VR, GIGXR, Medicalholodeck, PrecisionOS, SphereGen Technologies LLC, XRHealth, and others. The market players are considerably contributing to the market growth by the adoption of various strategies including mergers and acquisitions, partnerships, collaborations, funding, and new product launches, to stay competitive in the market. For instance, in January 2021, Hologic, Inc. acquired Biotheranostics, Inc., a privately held, commercial-stage Company that provides molecular diagnostic tests for breast and metastatic cancers, for approximately $230 million. By acquiring Biotheranostics, Hologic, Inc. may launch its venture into a sizable and rapidly expanding oncology adjacency, which aligns with their larger company objectives.